Herranz M - Search Results

1

Medical chemistry to spy cancer stem cells from outside the body.

Herranz M, Sánchez-García I. Herranz M, et al. Mini Rev Med Chem. 2007 Aug;7(8):781-91. doi: 10.2174/138955707781387894. Mini Rev Med Chem. 2007. PMID: 17692040 Review.

2

Adipose tissue mass is modulated by SLUG (SNAI2).

Pérez-Mancera PA, Bermejo-Rodríguez C, González-Herrero I, Herranz M, Flores T, Jiménez R, Sánchez-García I. Pérez-Mancera PA, et al. Among authors: herranz m. Hum Mol Genet. 2007 Dec 1;16(23):2972-86. doi: 10.1093/hmg/ddm278. Epub 2007 Sep 28. Hum Mol Genet. 2007. PMID: 17905753

3

Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.

Ropero S, Setien F, Espada J, Fraga MF, Herranz M, Asp J, Benassi MS, Franchi A, Patiño A, Ward LS, Bovee J, Cigudosa JC, Wim W, Esteller M. Ropero S, et al. Among authors: herranz m. Hum Mol Genet. 2004 Nov 15;13(22):2753-65. doi: 10.1093/hmg/ddh298. Epub 2004 Sep 22. Hum Mol Genet. 2004. PMID: 15385438

4

The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.

Ballestar E, Ropero S, Alaminos M, Armstrong J, Setien F, Agrelo R, Fraga MF, Herranz M, Avila S, Pineda M, Monros E, Esteller M. Ballestar E, et al. Among authors: herranz m. Hum Genet. 2005 Jan;116(1-2):91-104. doi: 10.1007/s00439-004-1200-0. Epub 2004 Nov 11. Hum Genet. 2005. PMID: 15549394

5

DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.

Herranz M, Esteller M. Herranz M, et al. Methods Mol Biol. 2007;361:25-62. doi: 10.1385/1-59745-208-4:25. Methods Mol Biol. 2007. PMID: 17172706 Review.

6

Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.

De la Cueva E, García-Cao I, Herranz M, López P, García-Palencia P, Flores JM, Serrano M, Fernández-Piqueras J, Martín-Caballero J. De la Cueva E, et al. Among authors: herranz m. Oncogene. 2006 Jul 6;25(29):4128-32. doi: 10.1038/sj.onc.1209432. Epub 2006 Feb 6. Oncogene. 2006. PMID: 16462758

7

A new candidate site for a tumor suppressor gene involved in mouse thymic lymphomagenesis is located on the distal part of chromosome 4.

Santos J, Herranz M, Pérez de Castro I, Pellicer A, Fernández-Piqueras J. Santos J, et al. Among authors: herranz m. Oncogene. 1998 Aug 20;17(7):925-9. doi: 10.1038/sj.onc.1202009. Oncogene. 1998. PMID: 9780010

8

A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors.

Fraga MF, Herranz M, Espada J, Ballestar E, Paz MF, Ropero S, Erkek E, Bozdogan O, Peinado H, Niveleau A, Mao JH, Balmain A, Cano A, Esteller M. Fraga MF, et al. Among authors: herranz m. Cancer Res. 2004 Aug 15;64(16):5527-34. doi: 10.1158/0008-5472.CAN-03-4061. Cancer Res. 2004. PMID: 15313885

9

The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma.

Herranz M, Martín-Caballero J, Fraga MF, Ruiz-Cabello J, Flores JM, Desco M, Marquez V, Esteller M. Herranz M, et al. Blood. 2006 Feb 1;107(3):1174-7. doi: 10.1182/blood-2005-05-2033. Epub 2005 Oct 20. Blood. 2006. PMID: 16239434 Free article.

10

New therapeutic targets in cancer: the epigenetic connection.

Herranz M, Esteller M. Herranz M, et al. Clin Transl Oncol. 2006 Apr;8(4):242-9. doi: 10.1007/BF02664934. Clin Transl Oncol. 2006. PMID: 16648099 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

391 results

Search Page